We fund early-stage health startups with the strategic insight of a top advisory firm.
As a strategy firm with a venture arm, we go beyond capital, bringing deep life sciences expertise, hands-on operational support, and a powerful industry network. Where capital meets consulting, we help founders move faster, think bigger, and execute smarter.
In 2024, only 2% of U.S. venture funding went to startups founded solely by women (Pitchbook, 2025).
We’re women-led—and investing to change the stats.
Fewer than 1 in 4 U.S. pharma companies have successfully scaled AI beyond the pilot phase (McKinsey & Company, 2025).
We know why—and guide AI-native startups through the friction to real partnerships.
Healthcare AI is growing at 37% annually and is projected to reach $188B by 2030, fueled by U.S. breakthroughs (The Research Insights, 2025).
We back the startups driving life sciences’ AI transformation.
